Show simple item record

dc.contributor.authorEvangelopoulos, D
dc.contributor.authorProsser, GA
dc.contributor.authorRodgers, A
dc.contributor.authorDagg, BM
dc.contributor.authorKhatri, B
dc.contributor.authorHo, MM
dc.contributor.authorGutierrez, MG
dc.contributor.authorCortes, T
dc.contributor.authorde, Carvalho, LPS
dc.date.accessioned2019-10-07T15:16:44Z
dc.date.available2019-10-07T15:16:44Z
dc.date.issued2019en
dc.identifier.citationEvangelopoulos D, Prosser GA, Rodgers A, Dagg BM, Khatri B, Ho MM, et al. Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes. Nat Commun. 2019 Sep 13;10(1):4177.en
dc.identifier.pmid31519879en
dc.identifier.doi10.1038/s41467-019-12074-zen
dc.identifier.urihttp://hdl.handle.net/10541/622213
dc.description.abstractDrug resistant infections represent one of the most challenging medical problems of our time. D-cycloserine is an antibiotic used for six decades without significant appearance and dissemination of antibiotic resistant strains, making it an ideal model compound to understand what drives resistance evasion. We therefore investigated why Mycobacterium tuberculosis fails to become resistant to D-cycloserine. To address this question, we employed a combination of bacterial genetics, genomics, biochemistry and fitness analysis in vitro, in macrophages and in mice. Altogether, our results suggest that the ultra-low rate of emergence of D-cycloserine resistance mutations is the dominant biological factor delaying the appearance of clinical resistance to this antibiotic. Furthermore, we also identified potential compensatory mechanisms able to minimize the severe fitness costs of primary D-cycloserine resistance conferring mutations.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1038/s41467-019-12074-zen
dc.titleComparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypesen
dc.typeArticleen
dc.contributor.departmentMycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UKen
dc.identifier.journalNature Communicationsen
dc.description.noteen]
refterms.dateFOA2019-10-27T19:09:43Z


Files in this item

Thumbnail
Name:
41467_2019_Article_12074.pdf
Size:
1.013Mb
Format:
PDF
Description:
Full text, Open Access article
Thumbnail
Name:
562107.pdf
Size:
1.013Mb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record